Seres Therapeutics, Inc. (MCRB)
14.63
+0.67
(+4.80%)
USD |
NASDAQ |
Feb 09, 16:00
14.49
-0.14
(-0.96%)
After-Hours: 20:00
Seres Therapeutics EPS Diluted (Quarterly) : 0.9353 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Altimmune, Inc. | -0.2126 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 8.204M |
| Revenue (Quarterly) | 0.351M |
| Total Expenses (Quarterly) | -7.853M |
| Enterprise Value | 165.69M |
| Gross Profit Margin (Quarterly) | -197.4% |
| Earnings Yield | 4.15% |
| Normalized Earnings Yield | 4.149 |